ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $944,219 | -5.1% | 45,308 | +9.1% | 0.00% | 0.0% |
Q2 2023 | $994,811 | +107.7% | 41,537 | +63.2% | 0.00% | +100.0% |
Q1 2023 | $478,856 | +12.7% | 25,444 | +54.6% | 0.00% | 0.0% |
Q1 2021 | $425,000 | -80.6% | 16,458 | -59.9% | 0.00% | -77.8% |
Q4 2020 | $2,194,000 | +15.5% | 41,038 | -10.9% | 0.01% | 0.0% |
Q3 2020 | $1,900,000 | -49.5% | 46,063 | -40.7% | 0.01% | -50.0% |
Q2 2020 | $3,766,000 | +36.4% | 77,704 | +18.9% | 0.02% | +5.9% |
Q1 2020 | $2,760,000 | +43.2% | 65,330 | +45.1% | 0.02% | +70.0% |
Q4 2019 | $1,927,000 | +29.2% | 45,033 | +8.6% | 0.01% | +25.0% |
Q3 2019 | $1,492,000 | +255.2% | 41,459 | +163.7% | 0.01% | +300.0% |
Q2 2019 | $420,000 | -52.6% | 15,720 | -52.4% | 0.00% | -60.0% |
Q1 2019 | $887,000 | -87.1% | 33,045 | -92.7% | 0.01% | -86.8% |
Q2 2018 | $6,877,000 | +1553.1% | 450,345 | +3425.2% | 0.04% | +850.0% |
Q1 2015 | $416,000 | – | 12,775 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |